Shrinking Genes - MDA Research for DMD Treatment

  • Thread starter Thread starter wasteofo2
  • Start date Start date
  • Tags Tags
    Genes
Click For Summary
SUMMARY

The discussion centers on the groundbreaking research by Jeffrey Chamberlain at the University of Washington, focusing on AAV-based gene therapy for Duchenne muscular dystrophy (DMD). Chamberlain has developed miniaturized dystrophin genes that can be packaged within AAV vectors, overcoming the limitation of the full-size dystrophin gene. Recent studies published in Nature Medicine demonstrate that these microdystrophin genes effectively correct muscle abnormalities in dystrophin-deficient mice, indicating a significant advancement in DMD treatment strategies.

PREREQUISITES
  • Understanding of AAV (Adeno-Associated Virus) gene therapy
  • Knowledge of dystrophin and its role in muscle function
  • Familiarity with genetic engineering techniques
  • Basic concepts of molecular biology, particularly gene structure and function
NEXT STEPS
  • Research the mechanisms of AAV vector packaging and delivery
  • Explore the implications of microdystrophin in clinical trials for DMD
  • Investigate gene editing techniques such as CRISPR for potential applications in gene therapy
  • Study the role of introns and enhancer sites in gene expression and their relevance in gene therapy
USEFUL FOR

This discussion is beneficial for molecular biologists, genetic engineers, clinical researchers, and anyone involved in the development of gene therapies for muscular dystrophies.

wasteofo2
Messages
477
Reaction score
2
this is an exerpt from this article: http://www.mdausa.org/publications/Quest/q92resup.cfm#mdasgenetherapy


"Meanwhile, MDA is also laying the groundwork for a clinical trial of AAV-based gene therapy for Duchenne muscular dystrophy (DMD). DMD results from any of a number of mutations in a large gene for the muscle protein known as dystrophin. The full-size gene can't be packaged inside an AAV vector.

To overcome this problem, MDA grantee Jeffrey Chamberlain, a molecular biologist at the University of Washington in Seattle, has developed highly miniaturized dystrophin genes that lead to the production of small proteins. Studies using these microdystrophin genes, which were published in the March issue of Nature Medicine, showed extremely promising results in correcting muscle abnormalities in dystrophin-deficient mice."

I'm shocked. I had no idea that genes, or anything of that sort could be shrunken at all, and the way which they say it makes it sound like a relatively easy thing to do. Has anyone ever heard of a process able to shrink down genes, or any other parts of cells? Would it be at all possible to shrink organelles, or perhaps make a virus which would alter the genes of a cell to make everything smaller as a whole when it divides?
 
Last edited by a moderator:
Biology news on Phys.org
So... if I understand correctly basically they got rid of all the introns, enhancer sites that weren't strictly needed, proteins that weren't strictly needed, and a bunch of other redundant junk?

Pretty clever actually.
 

Similar threads

  • · Replies 1 ·
Replies
1
Views
12K